These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2885864)

  • 41. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the meaning of electrodermal nonresponding in schizophrenia.
    Straube ER
    J Nerv Ment Dis; 1979 Oct; 167(10):601-11. PubMed ID: 490147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autonomic nervous system activity in acute schizophrenia: II. relationships to short-term prognosis and clinical state.
    Zahn TP; Carpenter WT; McGlashan TH
    Arch Gen Psychiatry; 1981 Mar; 38(3):260-6. PubMed ID: 7212956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment.
    Kaneko M; Honda K; Kanno T; Horikoshi R; Manome T; Watanabe A; Kumashiro H
    Neuropsychobiology; 1992; 25(3):126-9. PubMed ID: 1357582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of the Kamin blocking effect in acute but not chronic schizophrenics.
    Jones SH; Gray JA; Hemsley DR
    Biol Psychiatry; 1992 Nov; 32(9):739-55. PubMed ID: 1360261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test.
    Mass R; Wolf K; Wagner M; Haasen C
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):24-30. PubMed ID: 10738861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia.
    Green MF; Nuechterlein KH
    Psychiatry Res; 1988 Apr; 24(1):79-86. PubMed ID: 2899332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential response to amphetamine in schizophrenia.
    Cesarec Z; Nyman AK
    Acta Psychiatr Scand; 1985 May; 71(5):523-38. PubMed ID: 2861718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
    Green MF; Nuechterlein KH; Satz P
    Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lateralized attentional deficits in drug-free and medicated schizophrenic patients.
    Wigal SB; Swanson JM; Potkin SG
    Neuropsychologia; 1997 Dec; 35(12):1519-25. PubMed ID: 9460721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics.
    Spohn HE; Lacoursiere RB; Thompson K; Coyne L
    Arch Gen Psychiatry; 1977 Jun; 34(6):633-44. PubMed ID: 326215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia.
    Iwamoto Y; Kawanishi C; Kishida I; Furuno T; Fujibayashi M; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
    BMC Psychiatry; 2012 Nov; 12():199. PubMed ID: 23151241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of neuroleptic on-drug response in schizophrenic in-patients by EEG.
    Ulrich G; Gaebel W; Pietzcker A; Müller-Oerlinghausen B; Stieglitz RD
    Eur Arch Psychiatry Neurol Sci; 1988; 237(3):144-55. PubMed ID: 2898366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Covariation between two-flash threshold and skin conductance level in first-breakdown schizophrenics: relationships in drug-free patients and effects of treatment.
    Claridge G; Clark K
    Psychiatry Res; 1982 Jun; 6(3):371-80. PubMed ID: 6125983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrodermal activity as a predictor of social functioning in female schizophrenics.
    Wieselgren IM; Ohlund LS; Lindström LH; Ohman A
    J Abnorm Psychol; 1994 Aug; 103(3):570-5. PubMed ID: 7930057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered balance in the autonomic nervous system in schizophrenic patients.
    Nielsen BM; Mehlsen J; Behnke K
    Clin Physiol; 1988 Apr; 8(2):193-9. PubMed ID: 2896084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficits in initial feature registration of schizophrenics and substance abusers.
    Schwartz BD; Evans WJ; Sautter F; Pena JM; Winstead DK
    Schizophr Res; 1992 Sep; 7(3):217-24. PubMed ID: 1356425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug therapy in schizophrenia--variability of outcome and prediction of response.
    Awad AG
    Can J Psychiatry; 1989 Oct; 34(7):711-20. PubMed ID: 2572318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Season of birth and electrodermal unresponsiveness in male schizophrenics.
    Ohlund LS; Ohman A; Alm T; Ost LG; Lindström LH
    Biol Psychiatry; 1990 Feb; 27(3):328-40. PubMed ID: 2302440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.